Aptose Biosciences
APTO
#10445
Rank
A$6.2 M
Marketcap
A$2.43
Share price
0.00%
Change (1 day)
739.32%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -A$31.68 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$35.85 Million, an increase over its 2023 earnings that were of -A$74.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.68 Million-11.62%
2024 -A$35.85 Million-51.82%
2023 -A$74.4 Million22.9%
2022 -A$60.54 Million-34.91%
2021 -A$93.01 Million17.36%
2020 -A$79.25 Million107.65%
2019 -A$38.17 Million-7.73%
2018 -A$41.37 Million160.68%
2017 -A$15.87 Million-20.27%
2016 -A$19.91 Million28.71%
2015 -A$15.47 Million
2013 -A$8.77 Million
2010 -A$7.47 Million-8.31%
2009 -A$8.15 Million
2006 -A$15.1 Million-156.93%
2005 A$26.51 M-185.16%
2004 -A$31.14 Million458.58%
2003 -A$5.58 Million-63.66%
2002 -A$15.34 Million-8.04%
2001 -A$16.68 Million16.73%
2000 -A$14.29 Million294.99%
1999 -A$3.62 Million-6.51%
1998 -A$3.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-A$89.21 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-A$95.94 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$48.35 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA